Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RHOBTB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TMCO1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CRHR1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CNGA4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | AP3M2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLCH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DCLK3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FLRT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DVL3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DPY19L3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |